The Role of Gabapentin in Postoperative Pain and Epithelialization After Photorefractive Keratectomy

July 27, 2015 updated by: ALEJANDRO LICHTINGER, Codet Vision Institute

The Role of Gabapentin in Postoperative Pain and Epithelialization After Photorefractive Keratectomy A Prospective, Randomized, Double Blinded, Placebo Controlled Study

The primary aims of this study are to determine if treatment with Gabapentin taken systemically (oral tablets) in patients who have photorefractive keratectomy (PRK) surgical treatments reduces post surgical neuropathic pain and discomfort. The investigators main Hypothesis is that gabapentin given prior to and after refractive surgery prevents central sensitization and local allodynia.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Baja California
      • Tijuana, Baja California, Mexico, 22320
        • CODET Vision Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Subjects must be at least 18 years of age
  2. Subjects must not have any corneal disease or degeneration
  3. Subjects must be candidates for LASIK or PRK refractive surgery

Exclusion Criteria:

  1. History of topical ocular medications within 4 weeks prior to enrollment
  2. History of conjunctivitis or ocular inflammation within 4 weeks prior to enrollment
  3. History of a previous refractive surgery
  4. History of previous diagnosis of corneal disease, degeneration, or glaucoma
  5. History of autoimmune disease
  6. History of oral anti-histamines currently or within 1 week of study enrollment
  7. History of systemic anti-inflammatory or pain medication currently or within 4 weeks of study enrollment
  8. Use of oral diuretics or betablocker currently or within 1 week of study enrollment
  9. Current diagnosis of dry eye
  10. Patients whose Best corrected vision is less than 20/20
  11. Patients whose target post operative refraction is not plano
  12. Pregnant and lactating

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GABAPENTIN
Group of patients treated with oral gabapentin
Gabapentin PO. (300MG) 1 capsule the night before surgery, q12hrs the day of surgery and q8hrs for the firt 3 postoperative days.
Placebo Comparator: PLACEBO
Group given the placebo capsules
Sugar pill. One capsule given the night before surgery, q12hrs on the day of surgery and q8hrs for the first 3 postoperative days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain at moment of examination
Time Frame: 24 hours postoperatively

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

24 hours postoperatively
Average pain for the previous 24 hour period,
Time Frame: assesed at 24 hours
Numerical visual scale questionnaire, a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded
assesed at 24 hours
Maximum pain intensity for the previous 24 hour period
Time Frame: Assesed at 24 hours postoperatively
In a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded.
Assesed at 24 hours postoperatively
Pain at moment of examination
Time Frame: 48 hours postoperatively

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

48 hours postoperatively
pain on examination
Time Frame: 72 hours postoperatively

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

72 hours postoperatively
pain on examination
Time Frame: 96 hours ostoiperatively

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

96 hours ostoiperatively
Pain at moment of examination
Time Frame: postoperative day 7

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

postoperative day 7
Average pain for the previous 24 hour period
Time Frame: Assesed at 48 hours

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

Assesed at 48 hours
Average pain during the previous 24 hour period
Time Frame: Assesed at 72 hours postoperatively

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

Assesed at 72 hours postoperatively
Average pain for the last 24 hours period
Time Frame: Assesed at 96 hours postoperatively

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

Assesed at 96 hours postoperatively
Average pain since last examination
Time Frame: Assesed on postopertive day 7

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

Assesed on postopertive day 7
Maximum pain intensity for the previous 24 hour period
Time Frame: Assesed at 48 hours postoperatively

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

Assesed at 48 hours postoperatively
Maximum pain intensity for the previous 24 hour period
Time Frame: Assesed at 72 hours postoperatively

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

Assesed at 72 hours postoperatively
Maximum pain intensity for the last 24 hour period
Time Frame: Assesed at 96 hours postoperatively

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

Assesed at 96 hours postoperatively
Maximum pain intensity since the last examination
Time Frame: Assesed on the 7th postoperative day

Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded

Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day

Assesed on the 7th postoperative day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time required for complete healing
Time Frame: Evaluated each day until complete healing
Slit lamp observation of the epithelial defect and time until removal of contact lens.
Evaluated each day until complete healing
Visual acuity
Time Frame: every day until complete healing and at the 7th day postop
Snellen Chart
every day until complete healing and at the 7th day postop
Foreign body sensation
Time Frame: Every 24 hours until complete healing and at the 7th day postop
Numerical visual scale, In a scale from 0-10 where 0 is the least amount of foreign body sensation and 10 being the most.
Every 24 hours until complete healing and at the 7th day postop
Light sensitivity
Time Frame: Every 24 hours until complete healing and at the 7th day postop
Numerical visual scale, in a scale from 0-10 where 0 is the least amount of light sensitibity and 10 being the most.
Every 24 hours until complete healing and at the 7th day postop
Tearing and watery eyes
Time Frame: Every 24 hours until complete healing and at the 7th day postop
Numerical visual scale questionaire, In a scale from 0-10 where 0 is the least amount of tearing and 10 being the most.
Every 24 hours until complete healing and at the 7th day postop
Eye discomfort
Time Frame: Every 24 hours until complete healing and at the 7th day postop
Numerical visual scale questionnaire, In a scale from 0-10 where 0 is the least amount of discomfort and 10 being the most.
Every 24 hours until complete healing and at the 7th day postop
Dizziness
Time Frame: Every 24 hours until complete healling and at the 7th day postop
Numerical visual scale, scale from 0-10 where 0 is the least dizzy and 10 being the most.
Every 24 hours until complete healling and at the 7th day postop
lethargy
Time Frame: Every 24 hours until complete healing and at the 7th day postop
Numerical visual scale, In a scale from 0-10 where 0 is the least lethargic and 10 is the most.
Every 24 hours until complete healing and at the 7th day postop
Headache
Time Frame: Every 24 hours until complete healing and at the 7th day postop
Numerical visual scale, In a scale from 0-10 where 0 is the least amount of headache and 10 being the most severe headache felt.
Every 24 hours until complete healing and at the 7th day postop
Gastro-intestinal symptoms
Time Frame: Every 24 hours until complete healing and at the 7th day postop
Numerical visual scale, In a scale from 0-10 where 0 is the least amount of symptoms and 10 being the most symptoms.
Every 24 hours until complete healing and at the 7th day postop

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2010

Primary Completion (Actual)

September 1, 2010

Study Completion (Actual)

November 1, 2010

Study Registration Dates

First Submitted

April 23, 2010

First Submitted That Met QC Criteria

August 5, 2010

First Posted (Estimate)

August 9, 2010

Study Record Updates

Last Update Posted (Estimate)

July 29, 2015

Last Update Submitted That Met QC Criteria

July 27, 2015

Last Verified

July 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain After Photorefractive Keratectomy

Clinical Trials on Gabapentin

Subscribe